Mosaic ImmunoEngineering (CPMV) Revenue (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted quarterly Revenue of $47587.0 for Q4 2011, down 34.61% year-over-year from $72775.0 in Q4 2010, and down 64.64% quarter-over-quarter from $134563.0 in Q3 2011.
Mosaic ImmunoEngineering (CPMV) Revenue (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering's Revenue history runs 2 years deep, the most recent figure standing at $47587.0 for Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2011 | 47,587.00 |
| Aug 31, 2011 | 134,563.00 |
| Nov 30, 2010 | 72,775.00 |
| Aug 31, 2010 | 94,055.00 |